A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This study will test whether giving nivolumab in combination with pemetrexed and either
cisplatin or carboplatin before surgery is a safe and effective approach to treating
resectable mesothelioma without delaying surgery.